When it comes to global demand, few active pharmaceutical ingredients rival Ibuprofen, a widely trusted, fast-acting NSAID used across hospitals, retail shelves, and emergency protocols.
But behind every approved formulation is something invisible yet critical: a Drug Master File (DMF). For procurement heads, regulatory professionals, and sourcing strategists, understanding the Ibuprofen DMF landscape is essential to de-risk decisions and ensure compliance.
In this blog, we break down what makes Ibuprofen a regulatory staple, explore Ibuprofen DMF trends, and highlight top manufacturers.
Let’s dive in.
Ibuprofen doesn’t just sit on pharmacy shelves—it powers through inflammation, pain, and fever in over 100 countries.
Discovered in the early 1960s by Dr. Stewart Adams and his team at Boots UK, the drug was initially developed as a safer alternative to aspirin. By 1969, it gained approval in the UK. Five years later, it entered the U.S. market.
Ibuprofen is classified as a, nonsteroidal anti-inflammatory drug (NSAID)—specifically, a derivative of propionic acid. Its chemical name: isobutylphenylpropionic acid. What makes it effective is its ability to block COX-1 and COX-2 enzymes. When those are suppressed, the body produces fewer prostaglandins—the chemical messengers behind pain, fever, and inflammation.
The drug is formulated for multiple delivery systems: oral tablets and suspensions, topical creams, and even intravenous infusions. Most patients feel relief within 30 to 60 minutes.
Doctors reach for Ibuprofen because it works—and fast. It’s routinely used to treat:
Because of its wide utility, Ibuprofen has become a staple in medicine cabinets, hospitals, and emergency kits. It’s also included in the World Health Organization’s Model List of Essential Medicines, a list reserved for drugs considered critical for global health.
In pharmaceuticals, trust is essential, but so is confidentiality. That’s where the Drug Master File (DMF) comes in.
A DMF is a confidential regulatory document submitted to authorities like the US FDA, EDQM, or WHO. It contains detailed information about the manufacturing, processing, and control of an active pharmaceutical ingredient (API), excipient, or packaging component.
Instead of disclosing sensitive data to every client, manufacturers file a DMF once—and authorize access as needed.
The core goal of a DMF is to:
Once filed, the DMF acts as a secure reference for multiple applications—without repeated submissions.
While several types exist, the most relevant for APIs is the Type II DMF.
DMF Type |
Purpose |
Type 2 |
Drug Substance, Drug Intermediate, or Material used in preparation of the drug |
Type 3 |
Packaging materials |
Type 4 |
Excipients |
Type 5 |
FDA-accepted reference info |
Note: Type I DMFs (Facility/Site) are now obsolete under US FDA guidelines.
If you're sourcing Ibuprofen, your first question should be: Is there a valid DMF on file? If not, walk away.
As of 2024, over 77 US-DMFs for Ibuprofen have been submitted to the U.S. Food and Drug Administration (USFDA). These filings come from leading API manufacturers like IOL Chemicals, BASF, Granules India, and Shandong Xinhua.
Multiple companies hold more than one DMF, often reflecting process improvements or updated compliance data.
These DMFs are typically Type II, specific to the drug substance—and are key indicators of a manufacturer’s regulatory strength.
While the U.S. hosts the largest volume of filings, Ibuprofen is regulated globally under multiple frameworks:
Region |
Filling Type |
Availability |
United States |
USDMF |
77+ filings |
Europe |
CEP (COS) |
Available |
Japan |
JDMF |
Available |
Korea |
KDMF |
Available |
Canada |
CDMF |
Available |
WHO |
WHO PQ |
Available |
Note: Not all manufacturers file globally, but top-tier suppliers submit across multiple agencies—maximizing market access.
Filings for Ibuprofen DMFs began in the late 20th century and accelerated after the patent expired in 1985. Over the last decade, updates have increased due to:
Here’s a rough timeline to illustrate the trend:
Year Range |
Filling Volume Trend |
Pre 2000 |
Steady, Low volume |
2000 – 2010 |
Moderate growth |
2011 – 2020 |
Significant increase |
2021 – 2024 |
Sustained momentum |
Top leading pharma database provider in India such that Chemxpert Database—let you filter API suppliers by DMF type, geography, and regulatory approvals in seconds. It’s speed with compliance built-in.
If you're evaluating Ibuprofen suppliers, don’t just ask for samples, ask for their DMF history. It’s your shortcut to trust.
More than 70 companies globally have filed USDMFs for Ibuprofen, but only a handful stand out in both regulatory strength and market reliability.
Here are some of the top names:
Manufacturer |
Country |
DMF Status |
IOL Chemicals & Pharmaceuticals |
India |
Active |
Granules India |
India |
Active |
BASF |
Germany |
Active |
Shandong Xinhua Pharmaceutical |
China |
Active |
Solara Active Pharma Sciences |
India |
Active |
Mallinckrodt Pharmaceuticals |
USA |
Active |
Albemarle Corporation |
USA |
Active |
SMS Pharmaceuticals |
India |
Active |
Wanbury Limited |
India |
Active |
Catalent Pharma Solutions |
USA |
Active |
Several of these firms have filed multiple DMFs over time—often signaling process innovation or compliance upgrades.
When shortlisting Ibuprofen API suppliers, regulatory filing is just the beginning. You should also evaluate:
With our powerful and most updated pharma database, all these information is just a single click away, so you don’t have to toggle between PDFs or spreadsheets. Chemxpert Database provides you all the latest information at a single platform.
In pharma, the real leverage isn’t in the product—it’s in the data behind it. And Ibuprofen? It’s not just another over-the-counter painkiller. It’s a global commodity driven by compliance, credibility, and control.
With 77+ USDMFs, a legacy of safety, and wide therapeutic demand, Ibuprofen is one of the most actively regulated APIs on the planet. But the smartest companies aren’t just sourcing it. They’re vetting every DMF. Every audit. Every update.
That’s how leaders operate.
They don’t guess. They move fast, with clarity. And that’s what Chemxpert Database delivers: real-time regulatory intel, global DMF coverage, and supplier insights, all in one platform. No fluff. No friction. Just facts that close the gap between decision and execution.
So here’s the play: if you’re not using a platform like Chemxpert Database, you’re not sourcing—you’re gambling.
Make your next move a calculated one.
1. What is the USDMF number for Ibuprofen?
The USDMF number for Ibuprofen varies by manufacturer. Each approved supplier has a unique Drug Master File number registered with the USFDA. You can view and verify these numbers through trusted platforms like Chemxpert Database or the FDA DMF database.
2. How many Ibuprofen suppliers are DMF-approved in India?
As of 2024, more than 15 Indian manufacturers hold active US DMFs for Ibuprofen. Leading names include IOL Chemicals, Granules India, Solara Active Pharma Sciences, and SMS Pharmaceuticals. Platforms like Chemxpert Database offer filtered lists of India-based, DMF-approved Ibuprofen API suppliers with up-to-date compliance data.
3. What’s the difference between USDMF and CEP?
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!